Baby Boomers Discover the Best Brain Health Supplement Called Sophrosyne.
America’s Newest Brain Health Supplement comes in a Small Capsule, but its benefits are HUGE!
Sophrosyne is a First-of-its-Kind Clinically Proven Breakthrough Brain Health Supplement which contains a unique combination of four mind-boosting ingredients, all are clinically proven to improve brain cognition and memory.
“This is great news for Baby Boomers with their aging minds who want to sharpen and prolong their memory,” said Dr. Daryl Jones, a top neuroscientist, and CEO of Jonescientific, who led the development of Sophrosyne after years of clinical research and testing.
Dr. Daryl Jones – a Neuroscientist who has done extensive research on Alzheimer’s and Chronic Traumatic Encephalopathy (CTE) – and his team has scientifically researched and evaluated literally hundreds of ingredients for their memory and cognition-building properties.
Sophrosyne was the outcome of this extensive research, which found that its unique mixture of clinically proven ingredients at clinically active doses, has shown to considerably improve brain cognition, short and long term memory as well as overall good brain health.
The fact is, no other known Brain Health Product in the United States on the market today has been actually developed by a Neuroscientist; a Neuroscientist being is an expert in the development and function of the nervous system – including the brain.
“There is nothing as effective as Sophrosyne for improving brain health on the market today, says Dr. Jones”
Here’s a breakdown of the ingredients for Sophrosyne from Dr. Jones:
This plant, commonly known as Indian Ginseng, Ashwagandha or Winter Cherry, has been proven to regenerate damaged brain cells.
A natural chemical produced by certain plants has shown to help maintain a healthy environment within the brain by removing unwanted proteins. An 18-month UCLA Human Clinical Trial confirmed that consuming 180 mg of curcumin per day led to significantly enhanced memory and focus.
This herb has been demonstrated to enhance cognition and memory as well as decrease the rate of forgetting newly-acquired information. In at least four randomized, double-blind, placebo-controlled human trials – this herb was shown to prevent the breakdown of neurotransmitters essential for cognition and memory.
Also known as Lion’s Mane due to its unique appearance, this medicinal mushroom has been found to increase levels of peptides essential for the survival of brain cells. In a 16-week double-blind, parallel-group, placebo-controlled human trial, a high dose of this ingredient was found to improve cognitive function in Baby Boomers and Seniors.
A daily dose of Sophrosyne contains science-backed, clinically active doses of 500 mg of Withania Somnifera, 180 mg of curcumin, 300 mg of Bacopa Monnieri and 500 mg of Hericium Erinaceus.
“Our research shows that these four nootropic (cognitive enhancing) ingredients, consumed in a daily capsule, deliver the most impressive results in improving cognition and memory compared to any other supplement available on the market today,” said Dr. Jones.
BUY SOPHROSYNE HERE
Sophrosyne retails for $59.99 for a 90-capsule bottle (2 Capsules a day).
SPECIAL LIMITED TIME OFFER
Use introductory code BRAIN for $20 off each bottle of Sophrosyne
Use introductory code JONESCIENTIFIC for 20% off monthly subscriptions.
About Dr. Daryl Rhys Jones
Recognized as one of the top experts and researchers in the field of neuroscience, Dr. Jones has an impressive record of published works in scholarly journals which are widely relied upon by other scientists. His innovative research and discoveries, particularly in neurodegenerative diseases, continues to significantly contribute to the field of neuroscience. Among his contributions is the discovery that antibodies created in his laboratory against the infectious protein that causes currently-incurable Creutzfield-Jakob disease (CJD, the human form of “Mad Cow disease”) are able to cure prion-infected brain cells. Dr. Jones and his team later demonstrated that these newly-developed antibodies can also be adapted for the treatment of other diseases, including Alzheimer’s and Parkinson’s.